<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-210" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Drug Eluting Stent Compounds</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Senst</surname>
            <given-names>Benjamin</given-names>
          </name>
          <aff>Universit&#x000e4;tsklinikum Halle</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Borger</surname>
            <given-names>Judith</given-names>
          </name>
          <aff>Campbell Un. School of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Benjamin Senst declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Judith Borger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-210.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Drug-eluting stents (DES) are vascular prostheses used by interventional cardiologists to reopen and maintain&#x000a0;patent coronary arteries narrowed by arteriosclerosis. The history of interventional cardiology began with balloon angioplasty in 1977.&#x000a0;Sigwart et al. introduced the first bare metal stent (BMS) in 1986.<xref ref-type="bibr" rid="article-210.r1">[1]</xref> In 2002 the first DES came to the markets in Europe. Today many companies are offering diverse DES to improve the treatment of coronary artery disease.<xref ref-type="bibr" rid="article-210.r2">[2]</xref><xref ref-type="bibr" rid="article-210.r3">[3]</xref>&#x000a0;A multitude of studies providing evidence has paralleled this development. Real world practice emphasizes the clinical importance of stent technology illustrated by the fact that stent implantation occurs in 90% of PCI.</p>
        <p>Facing the&#x000a0;variety of DES, one can classify them according to three characteristics:</p>
        <list list-type="order">
          <list-item>
            <p>Scaffold</p>
          </list-item>
          <list-item>
            <p>Drug-delivery mechanism (i.e., polymer)</p>
          </list-item>
          <list-item>
            <p>Therapeutic agent</p>
          </list-item>
        </list>
        <p>The development of DES evolved through different generations. First-generation DES had a stainless steel scaffolding coated with either sirolimus or paclitaxel. The RAVEL, SIRIUS, and TAXUS trials evaluated first-generation DES.<xref ref-type="bibr" rid="article-210.r4">[4]</xref><xref ref-type="bibr" rid="article-210.r5">[5]</xref>&#x000a0;Since studies showed the superiority of rapamycin agents, the second generation DES carried everolimus or zotarolimus. Second-generation DES has a cobalt-chromium scaffolding with different polymer coatings which allows decreased strut thickness, improved flexibility, deliverability, enhanced biocompatibility, better eluting profiles, and superior re-endothelialization. The ENDEAVOR and SPIRIT trials tested second-generation drug-eluting stents which are now the predominant implanted stents.<xref ref-type="bibr" rid="article-210.r6">[6]</xref><xref ref-type="bibr" rid="article-210.r7">[7]</xref><xref ref-type="bibr" rid="article-210.r8">[8]</xref> The third generation of DES with a biodegradable polymer or entirely bioabsorbable scaffolds are just undergoing clinical testing.<xref ref-type="bibr" rid="article-210.r9">[9]</xref></p>
        <p>Stents&#x000a0;prevent the vascular recoil cardiologists observed with balloon angioplasty (PTCA). Bare metal stents (BMS) are superior to PTCA alone as was shown&#x000a0;in the BENESTENT and STRESS trials.<xref ref-type="bibr" rid="article-210.r10">[10]</xref>&#x000a0;But following BMS implantation, restenosis develops in 30% of cases. Early restenosis&#x000a0;results from neointimal hyperplasia because of migration and proliferation of vascular smooth muscle cells as a response to vascular injury from the stent deployment.<xref ref-type="bibr" rid="article-210.r11">[11]</xref><xref ref-type="bibr" rid="article-210.r12">[12]</xref><xref ref-type="bibr" rid="article-210.r13">[13]</xref>&#x000a0;To reduce restenosis rate, DES evolved from BMS. Both share the common scaffold structure. But in drug-eluting stents, an antiproliferative drug coats the scaffold to&#x000a0;reduce cell proliferation inside the stent and also treat the complication of early restenosis.<xref ref-type="bibr" rid="article-210.r14">[14]</xref>&#x000a0;This development led to a significant reduction of early restenosis.&#x000a0;Long-term trials, however, revealed another problem, which is late (&#x0003e;30 days) and very&#x000a0;late (&#x0003e;12 months) stent thrombosis.<xref ref-type="bibr" rid="article-210.r15">[15]</xref><xref ref-type="bibr" rid="article-210.r16">[16]</xref><xref ref-type="bibr" rid="article-210.r17">[17]</xref>&#x000a0;Adequately powered long-term trials have shown that drug-eluting stents correlate with this complication. The reason for stent thrombosis is the antiproliferative effect of DES, which slows re-endothelialization of the prosthetic material. After cessation of oral&#x000a0;antiplatelet therapy, the uncovered scaffold material can&#x000a0;trigger platelet activation, and late restenosis or thrombosis occurs.<xref ref-type="bibr" rid="article-210.r18">[18]</xref><xref ref-type="bibr" rid="article-210.r19">[19]</xref>&#x000a0;Whereas restenosis due to neointimal hyperplasia is a slow process, stent thrombosis occurs suddenly with acute life-threatening symptoms. It has a low incidence but high mortality.<xref ref-type="bibr" rid="article-210.r20">[20]</xref>&#x000a0;Thus, anticoagulation is crucial after implantation of stents.<xref ref-type="bibr" rid="article-210.r21">[21]</xref>&#x000a0;</p>
        <p>Problems&#x000a0;with hypersensitivity to stents&#x000a0;have&#x000a0;been proposed and subsequently,&#x000a0;the concept of polymer-free or biodegradable&#x000a0;polymers&#x000a0;was&#x000a0;introduced. Recently&#x000a0;reestablishment of healthy long-term vasomotion with biodegradable stents&#x000a0;have gained significance.&#x000a0;</p>
        <p>Different characteristics make each drug-eluting stent unique. Each of them has advantages and disadvantages which derive from differences in drug-loading capacity, drug-release pharmacokinetics, polymer durability, biocompatibility, influence on vascular wall thinning, aneurysm formation, and delayed restenosis.<xref ref-type="bibr" rid="article-210.r22">[22]</xref>&#x000a0;Different complications can occur following the implantation of stents. Materials not native to the human body involve questions of biocompatibility. Problems of corrosion and release of toxic substances led to the investigation of more biocompatible and degradable&#x000a0;compounds. Early biocompatibility problems include stent thrombosis, inflammation, and neointima formation. A late problem associated with decreased biocompatibility is scaffold fracture due to&#x000a0;material fatigue.</p>
        <p>The FDA MAUDE database showed that most stent fractures do not trigger symptoms, are difficult to assess and thus, are probably under-recognized.<xref ref-type="bibr" rid="article-210.r23">[23]</xref> Risk factors for stent fracture are stent&#x000a0;length (5cm vs. 3cm) and stents placed in bypass grafts or the RCA location.<xref ref-type="bibr" rid="article-210.r24">[24]</xref><xref ref-type="bibr" rid="article-210.r25">[25]</xref><xref ref-type="bibr" rid="article-210.r26">[26]</xref>&#x000a0;The FDA requires manufacturers to demonstrate&#x000a0;10-year life duration for stents through stress testing.<xref ref-type="bibr" rid="article-210.r27">[27]</xref><xref ref-type="bibr" rid="article-210.r26">[26]</xref>&#x000a0;Stent fracture without restenosis treated only&#x000a0;conservatively&#x000a0;shows good outcomes.<xref ref-type="bibr" rid="article-210.r25">[25]</xref>&#x000a0;Malapposition is the problem of incomplete alignment of the stent struts to the vessel surface. It occurs in 2 to 5% of the cases and&#x000a0;is a cause of late stent thrombosis.<xref ref-type="bibr" rid="article-210.r28">[28]</xref><xref ref-type="bibr" rid="article-210.r29">[29]</xref></p>
      </sec>
      <sec id="article-210.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>The Scaffold</bold>
</p>
        <p>Stents can be classified according to characteristics like metallic basis and design.<xref ref-type="bibr" rid="article-210.r30">[30]</xref>&#x000a0;Different metallic compounds can serve as stent scaffold which gets further characterized by unique physical properties such as radial strength,&#x000a0;ferromagneticity, material fatigue, and radiolucency.<xref ref-type="bibr" rid="article-210.r31">[31]</xref> Radial strength measures the resistance to external compression. Radiolucency characterizes the visibility of the stent during angiography.</p>
        <p>Stainless steel or tantalum&#x000a0;was used in early BMS.<xref ref-type="bibr" rid="article-210.r31">[31]</xref>&#x000a0;Tantalum has a good visibility during angiography and lack of ferromagnetism. Following implantation, tantalum undergoes oxidation that makes it stable and resistant to degradation which results in better biocompatibility.<xref ref-type="bibr" rid="article-210.r32">[32]</xref><xref ref-type="bibr" rid="article-210.r33">[33]</xref>&#x000a0;Tantalum showed similar thrombogenicity but better radio-opacity compared to stainless steel and is appreciated for&#x000a0;its mechanical strength.<xref ref-type="bibr" rid="article-210.r34">[34]</xref><xref ref-type="bibr" rid="article-210.r32">[32]</xref> By comparison, 316L stainless steel&#x000a0;with low&#x000a0;carbon content is a mixture of iron, chromium, and nickel.</p>
        <p>Later on, nitinol, a combination of nickel and titanium, was introduced into clinical practice as it exhibited elastic properties and thermal shape memory.<xref ref-type="bibr" rid="article-210.r35">[35]</xref>&#x000a0;The thermal memory allows for the expansion of the nitinol stent once inside the body and smooth adaption to surrounding geometry.</p>
        <p>Recent&#x000a0;stent&#x000a0;backbones&#x000a0;are made from chromium combinations with either cobalt or platinum as they allow thin strut structure.&#x000a0;Cobalt chromium stents are a choice in higher-risk lesions due to their high radial strength, low profile and increased elasticity.<xref ref-type="bibr" rid="article-210.r36">[36]</xref><xref ref-type="bibr" rid="article-210.r37">[37]</xref>&#x000a0;Cobalt chromium&#x000a0;scaffolds (MP35N, L605) compared with stainless steel&#x000a0;scaffolds showed a lower risk for target vessel revascularization.<xref ref-type="bibr" rid="article-210.r38">[38]</xref><xref ref-type="bibr" rid="article-210.r39">[39]</xref><xref ref-type="bibr" rid="article-210.r40">[40]</xref>&#x000a0;The platinum chromium stent possesses characteristics of good flexibility, deliverability, conformability, radial strength, and visibility.<xref ref-type="bibr" rid="article-210.r41">[41]</xref></p>
        <p>Due to&#x000a0;improved scaffold materials having higher radial strength, strut thickness decreased from around 140 micrometers&#x000a0;in thick-strut stents to around 70 micrometers in thin-strut stents.&#x000a0;The ISAR-STEREO trial showed the superiority of thin-strut stents&#x000a0;with lower restenosis.<xref ref-type="bibr" rid="article-210.r42">[42]</xref><xref ref-type="bibr" rid="article-210.r43">[43]</xref></p>
        <p>The problem of metal&#x000a0;allergy plays no role in the pathogenesis of restenosis, but its influence on outcome shows contradictory evidence.<xref ref-type="bibr" rid="article-210.r44">[44]</xref><xref ref-type="bibr" rid="article-210.r45">[45]</xref><xref ref-type="bibr" rid="article-210.r46">[46]</xref> Some authors propose patch testing prior to implantation.&#x000a0;<xref ref-type="bibr" rid="article-210.r45">[45]</xref> Nickel is especially known for its allergic potential and has been banned&#x000a0;from textiles in many countries. Stainless steel, cobalt, chromium, and platinum chromium are the most commonly used alloys.<xref ref-type="bibr" rid="article-210.r27">[27]</xref></p>
        <p>Apart from the metallic basis, scaffold design has clinical implications as relates to vessel injury during implantation, and different designs result in different injury patterns with greater injury leading to increased tissue proliferation and platelet adhesion.&#x000a0;<xref ref-type="bibr" rid="article-210.r47">[47]</xref>&#x000a0;Stent designs include delta wing stent,<xref ref-type="bibr" rid="article-210.r48">[48]</xref> coil stent, tubular mesh stent, tubular slotted stent, and corrugated ring stent. The corrugated ring stent design showed less tissue proliferation than the&#x000a0;tubular slotted stent design.<xref ref-type="bibr" rid="article-210.r49">[49]</xref></p>
        <p>Multicellular stents can subdivide into closed-cell and open-cell designs. Closed-cell stents show a more uniform drug delivery but are less flexible, whereas open-cell stents have a non-uniform drug distribution but improved alignment to the vessel.<xref ref-type="bibr" rid="article-210.r50">[50]</xref><xref ref-type="bibr" rid="article-210.r51">[51]</xref> In the PAST study, closed-cell stents triggered less platelet adhesion.<xref ref-type="bibr" rid="article-210.r47">[47]</xref>&#x000a0;Uniform endothelial coverage&#x000a0;can be achieved&#x000a0;with flexible stent design and reduces stent thrombosis.<xref ref-type="bibr" rid="article-210.r52">[52]</xref></p>
        <p>Bioabsorbable stents&#x000a0;are non-permanent&#x000a0;implants avoiding caging vessels and obstructing side branches and allow vasomotion.<xref ref-type="bibr" rid="article-210.r48">[48]</xref>&#x000a0;They are made either from metallic or polymeric scaffolds. The basis of metallic biodegradable&#x000a0;scaffolds is magnesium or iron.&#x000a0;The pharmacological properties of these two compounds&#x000a0;are well known.<xref ref-type="bibr" rid="article-210.r53">[53]</xref> A growing number of synthetic or natural&#x000a0;polymers are available to create biodegradable scaffolds such as poly-(L-lactic acid) (PLLA) or amino acids such as tyrosine.<xref ref-type="bibr" rid="article-210.r54">[54]</xref><xref ref-type="bibr" rid="article-210.r53">[53]</xref>&#x000a0;</p>
        <p>
<bold>The Therapeutic Agent</bold>
</p>
        <p>Antiproliferative drugs stop vascular smooth muscle cell proliferation and thus, neointimal hyperplasia. Sirolimus and paclitaxel were used in first generation DES. Paclitaxel inhibits microtubule disassembly and thus interferes with the cell cycle, leading to cell cycle&#x000a0;arrest in G0-G1 and G2-M phases.<xref ref-type="bibr" rid="article-210.r55">[55]</xref> Sirolimus binds to the FKBP12 and subsequently inhibits mTOR and PI3 pathway, arresting the cell cycle in the G1 phase.<xref ref-type="bibr" rid="article-210.r56">[56]</xref><xref ref-type="bibr" rid="article-210.r57">[57]</xref>&#x000a0;In clinical studies (i.e., REALITY, SIRTAX, ISAR-DESIRE) sirolimus-eluting stents (SES) outperformed paclitaxel-eluting stents (PES) regarding restenosis rate.<xref ref-type="bibr" rid="article-210.r58">[58]</xref> Although both inhibit the cell cycle differences in dosage, release kinetics, immunosuppressive properties, and distribution&#x000a0;among the vessel wall layers might contribute to the clinical inferiority of paclitaxel-eluting stents.<xref ref-type="bibr" rid="article-210.r59">[59]</xref><xref ref-type="bibr" rid="article-210.r60">[60]</xref> Additionally, shear stress has been shown to&#x000a0;vary between these two stent types.<xref ref-type="bibr" rid="article-210.r61">[61]</xref></p>
        <p>Therefore, later generation stent therapeutic agents evolved from sirolimus. Changes to the sirolimus structure created compounds such as everolimus (SDZ RAD) which showed anti-arteriosclerotic features&#x000a0;and prevented graft rejection.<xref ref-type="bibr" rid="article-210.r62">[62]</xref><xref ref-type="bibr" rid="article-210.r63">[63]</xref>&#x000a0;Ridaforolimus was&#x000a0;non-inferior to zotarolimus in the BIONICS trial.<xref ref-type="bibr" rid="article-210.r64">[64]</xref>&#x000a0;Further rapamycin agents include biolimus and novolimus. Concerns about tissue factor increase as&#x000a0;a side&#x000a0;effect of rapamycin agents have related to stent thrombosis.<xref ref-type="bibr" rid="article-210.r65">[65]</xref></p>
        <p>Other investigated therapeutic agents are<xref ref-type="bibr" rid="article-210.r66">[66]</xref><xref ref-type="bibr" rid="article-210.r67">[67]</xref><xref ref-type="bibr" rid="article-210.r68">[68]</xref><xref ref-type="bibr" rid="article-210.r69">[69]</xref><xref ref-type="bibr" rid="article-210.r70">[70]</xref><xref ref-type="bibr" rid="article-210.r71">[71]</xref><xref ref-type="bibr" rid="article-210.r72">[72]</xref><xref ref-type="bibr" rid="article-210.r73">[73]</xref><xref ref-type="bibr" rid="article-210.r74">[74]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Dual drug-eluting stents DDES, which carry two therapeutic agents to combine their mechanism of action, for example antiproliferative and additional anti-thrombotic effects. The modification of the coating allows time controlled release of the drugs targeting the different timing of bio-response to stent implantation.</p>
          </list-item>
          <list-item>
            <p>Phytoncide (PTC), which shows the same anti-inflammatory and antiproliferative effects in vitro as sirolimus and thus might serve as an alternative to sirolimus</p>
          </list-item>
          <list-item>
            <p>Glucocorticoids, which are useful to suppress inflammatory changes that lead to restenosis</p>
          </list-item>
          <list-item>
            <p>Gene eluting stents, which deliver plasmid DNA to express appreciated proteins inside cells. The expression of VEGF, for example, supports healthy endothelialization of the stent luminal surface</p>
          </list-item>
          <list-item>
            <p>Galangin, which up-regulates p27KIP1&#x000a0;that arrests cell cycle in the G0-G1 phase, inhibits proliferation of vascular smooth muscle cells</p>
          </list-item>
          <list-item>
            <p>Tacrolimus&#x000a0;reduces restenosis via the calcineurin/NFAT/IL-2 pathway but is inferior in head-to-head comparison to other stents eluting rapamycin agents</p>
          </list-item>
          <list-item>
            <p>Stem-cell carrying stents to support healthy reendothelialization</p>
          </list-item>
          <list-item>
            <p>Radioactive stents</p>
          </list-item>
          <list-item>
            <p>Actinomycin</p>
          </list-item>
          <list-item>
            <p>Probucol</p>
          </list-item>
          <list-item>
            <p>7-Hexanoyltaxol</p>
          </list-item>
        </list>
        <p>
<bold>The Coating</bold>
</p>
        <p>Stent coating serves different purposes. It facilitates drug stent adhesion, drug-release, biocompatibility, and modulates thrombogenicity. Polymers are repeating sequences of chemical connections. Drug delivery via polymers follows the principle of diffusion, dissolution or ion exchange.<xref ref-type="bibr" rid="article-210.r75">[75]</xref>&#x000a0;The group of coating materials further subdivide as<xref ref-type="bibr" rid="article-210.r31">[31]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Organic&#x000a0;or inorganic</p>
          </list-item>
          <list-item>
            <p>Bio-erodable&#x000a0;or&#x000a0;permanent</p>
          </list-item>
          <list-item>
            <p>Uniform or nonuniform drug delivery</p>
          </list-item>
          <list-item>
            <p>Luminal or abluminal coating</p>
          </list-item>
          <list-item>
            <p>Active or passive</p>
          </list-item>
        </list>
        <p>First generation DES used synthetic polymers such as poly(ethylene-co-vinyl acetate) (PEVA) and poly(n-butyl methacrylate) (PBMA) or tri-block copolymer poly(styrene-b-isobtylene-b-styrene) (SIBS). PEVA and PBMA coat SES whereas SIBS coats PES. SIBS allows early burst release of the&#x000a0;drug which is&#x000a0;ideal for controlling the early vascular injury following stent implantation. Observations of late stent thrombosis with PEVA and PBMA&#x000a0;triggered investigations to find the underlying causes. Hypersensitivity arose as a factor as tissue surrounding stents became infiltrated by inflammatory cells.<xref ref-type="bibr" rid="article-210.r76">[76]</xref> To reduce inflammation following stenting, more biocompatible polymers such as phosphorylcholine (PC) and copolymer poly(vinylidene flouride-co-hexaflouropropylene) (PVDF-HFP)&#x000a0;coat second-generation drug-eluting stents. Phosphorylcholine&#x000a0;(PC) is a natural constituent of the phospholipid bilayer cell membrane. Since PC reduces platelet adhesion, it is useful to reduce thrombosis.&#x000a0;Large vessel grafts&#x000a0;are made from poly(bis(trifluoroethoxyl)phosphazene&#x000a0;(PTFE).</p>
        <p>Other coating options include<xref ref-type="bibr" rid="article-210.r77">[77]</xref><xref ref-type="bibr" rid="article-210.r78">[78]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gold-coated stents, which exhibited an increased risk for restenosis</p>
          </list-item>
          <list-item>
            <p>Heparin</p>
          </list-item>
          <list-item>
            <p>Endothelial cells or its progenitors</p>
          </list-item>
          <list-item>
            <p>CD34 antibodies</p>
          </list-item>
          <list-item>
            <p>Natural glycocalyx</p>
          </list-item>
        </list>
        <p>To further reduce the&#x000a0;inflammatory response, stent coatings employed bioabsorbable polymers&#x000a0;such as poly-lactic acid&#x000a0;(PLA), poly(lactide-co-glycolide) (PLGA) and polycaprolactone (PCL).<xref ref-type="bibr" rid="article-210.r79">[79]</xref><xref ref-type="bibr" rid="article-210.r80">[80]</xref>&#x000a0; Experience with PLA derives from the application in clinical practice as sutures or screws and grafts and meshes.<xref ref-type="bibr" rid="article-210.r81">[81]</xref><xref ref-type="bibr" rid="article-210.r82">[82]</xref>&#x000a0;A study comparing PLGA and PCL associated their different degradation to acidification of the surrounding tissue and cell proliferation and migration.<xref ref-type="bibr" rid="article-210.r83">[83]</xref>&#x000a0;Poly(lactic acid-co-glycolic acid) (PLGA) degrades by hydrolysis in 6 months. It exhibits low immunogenicity, good biocompatibility, and mechanical characteristics.<xref ref-type="bibr" rid="article-210.r84">[84]</xref>&#x000a0;Different trials (LEADERS, COMPARE II, NEXT, and CENTURY II)&#x000a0;showed promising results for biodegradable polymer thin-strut drug-eluting stents compared with thin-strut permanent polymer drug-eluting stents.<xref ref-type="bibr" rid="article-210.r85">[85]</xref><xref ref-type="bibr" rid="article-210.r86">[86]</xref>&#x000a0;</p>
        <p>The problems associated with coating polymers such as inflammation or hypersensitivity can be avoided altogether&#x000a0;by using drug reservoirs stents or nanoparticles.</p>
      </sec>
      <sec id="article-210.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The plentitude of different drug-eluting stents requires knowledge about their&#x000a0;characteristics to align the advantages and disadvantages&#x000a0;of the stent with the requirement of each unique lesion.&#x000a0;Stent performance depends strongly on lesion characteristics.<xref ref-type="bibr" rid="article-210.r87">[87]</xref> Arterial response to stent implantation is complex, and thus preclinical (i.e., animal) studies&#x000a0;are key&#x000a0;to predict&#x000a0;performance in humans.<xref ref-type="bibr" rid="article-210.r88">[88]</xref>&#x000a0;There is not&#x000a0;one ideal stent, but different stents are&#x000a0;better&#x000a0;suited&#x000a0;for different situations. For example, small diameter stents have been designed for narrow vessel treatment (&#x0003c;2.5 to 3.0mm).<xref ref-type="bibr" rid="article-210.r89">[89]</xref><xref ref-type="bibr" rid="article-210.r90">[90]</xref>&#x000a0;Since real-world experience showed frequent off-label usage, there has been a broadening of the indications for DES placement.<xref ref-type="bibr" rid="article-210.r91">[91]</xref>&#x000a0;</p>
        <p>New-generation&#x000a0;DES&#x000a0;can be&#x000a0;used&#x000a0;in complex lesions such as with diabetic patients,<xref ref-type="bibr" rid="article-210.r92">[92]</xref> chronic kidney disease,<xref ref-type="bibr" rid="article-210.r93">[93]</xref> acute myocardial infarction (as was investigated in the HORIZONS-AMI trial),<xref ref-type="bibr" rid="article-210.r94">[94]</xref> ostial lesions or bifurcations,<xref ref-type="bibr" rid="article-210.r95">[95]</xref> bypass grafts, as an alternative to coronary artery bypass grafting in left main stem disease,<xref ref-type="bibr" rid="article-210.r96">[96]</xref> small vessels or long lesions, restenosis, and chronic occlusions.</p>
        <p>Bare metal stents are not outdated, but drug-eluting stents have largely replaced them.<xref ref-type="bibr" rid="article-210.r39">[39]</xref> Some authors argue that practice adaption and application of DES has been too fast.<xref ref-type="bibr" rid="article-210.r14">[14]</xref>&#x000a0;BMS&#x000a0;are still&#x000a0;used in about 20% of PCI and&#x000a0;indicated in patients that have limited DAPT options (awaiting surgery, compliance issues, bleeding risk, preexisting atrial fibrillation). BMS may also&#x000a0;be preferable in large vessel lesions, acute myocardial infarction, and regarding costs.<xref ref-type="bibr" rid="article-210.r97">[97]</xref>&#x000a0;In the US, a BMS costs round about 1,000 USD and a DES around 3,000 USD. Comparing costs requires considering long-term outcomes that favor DES because of less reintervention and thus improved cost-benefit-analysis.<xref ref-type="bibr" rid="article-210.r98">[98]</xref><xref ref-type="bibr" rid="article-210.r99">[99]</xref><xref ref-type="bibr" rid="article-210.r100">[100]</xref></p>
        <p>The discussion about the appropriateness of real-world stenting practice is ongoing. For example, the NORSTENT study emphasized the advantages of BMS compared to DES. Designing studies and finding evidence is difficult, which can be illustrated by the fact that the progression of restenosis differs, which makes early angiographic measures unrelated to late stenotic changes. Measuring restenosis risk as a surrogate is common&#x000a0;among studies, but it may not correlate with clinical endpoints such as death and myocardial infarction.<xref ref-type="bibr" rid="article-210.r101">[101]</xref>&#x000a0;</p>
        <p>Evidence advocates for everolimus-eluting stents, which exhibit the most favorable outcomes and the future might&#x000a0;belong to biodegradable polymers and bioabsorbable scaffolds.<xref ref-type="bibr" rid="article-210.r102">[102]</xref><xref ref-type="bibr" rid="article-210.r103">[103]</xref>&#x000a0;Until now evidence did not show the superiority of bioresorbable scaffold stents over second-generation drug-eluting stents.<xref ref-type="bibr" rid="article-210.r48">[48]</xref>&#x000a0;Lee and Torre Hernandez describe in their article the ideal stent of the future as showing good deliverability,&#x000a0;having thin struts, being highly visible, carrying a rapamycin agent that is eluted for two to three months and being coated by a thin layer polymer allowing for&#x000a0;short duration DAPT.<xref ref-type="bibr" rid="article-210.r104">[104]</xref></p>
      </sec>
      <sec id="article-210.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=210&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=210">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/210/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=210">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-210.s5">
        <title>References</title>
        <ref id="article-210.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigwart</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Puel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirkovitch</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Joffre</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kappenberger</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.</article-title>
            <source>N Engl J Med</source>
            <year>1987</year>
            <month>Mar</month>
            <day>19</day>
            <volume>316</volume>
            <issue>12</issue>
            <fpage>701</fpage>
            <page-range>701-6</page-range>
            <pub-id pub-id-type="pmid">2950322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Htay</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stent: a review and update.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2005</year>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>263</fpage>
            <page-range>263-76</page-range>
            <pub-id pub-id-type="pmid">17315599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stents for coronary artery disease: a review.</article-title>
            <source>Med Eng Phys</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>148</fpage>
            <page-range>148-63</page-range>
            <pub-id pub-id-type="pmid">21075668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Shaughnessy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Turco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bergin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>ME</given-names>
              </name>
              <collab>TAXUS-IV Investigators</collab>
            </person-group>
            <article-title>One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Apr</month>
            <day>27</day>
            <volume>109</volume>
            <issue>16</issue>
            <fpage>1942</fpage>
            <page-range>1942-7</page-range>
            <pub-id pub-id-type="pmid">15078803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Shaughnessy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Turco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bergin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>ME</given-names>
              </name>
              <collab>TAXUS-IV Investigators</collab>
            </person-group>
            <article-title>A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Jan</month>
            <day>15</day>
            <volume>350</volume>
            <issue>3</issue>
            <fpage>221</fpage>
            <page-range>221-31</page-range>
            <pub-id pub-id-type="pmid">14724301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Meredith</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fajadet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wijns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2013</year>
            <month>May</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>504</fpage>
            <page-range>504-12</page-range>
            <pub-id pub-id-type="pmid">23602459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Cutlip</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Nikolsky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>O'Shaughnessy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Overlie</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>McLaurin</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tolleson</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Reen</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Kirtane</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <collab>ENDEAVOR IV Investigators</collab>
            </person-group>
            <article-title>A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2010</year>
            <month>Feb</month>
            <day>09</day>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>543</fpage>
            <page-range>543-54</page-range>
            <pub-id pub-id-type="pmid">20152559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Massaro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meredith</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wijns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fajadet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Cutlip</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>12</issue>
            <fpage>1240</fpage>
            <page-range>1240-9</page-range>
            <pub-id pub-id-type="pmid">21232717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hibbert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Froeschl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>The evolution of coronary stents: a brief review.</article-title>
            <source>Can J Cardiol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-45</page-range>
            <pub-id pub-id-type="pmid">24286961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eberhart</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Zilberman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Frenkel</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Bioresorbable polymeric stents: current status and future promise.</article-title>
            <source>J Biomater Sci Polym Ed</source>
            <year>2003</year>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>299</fpage>
            <page-range>299-312</page-range>
            <pub-id pub-id-type="pmid">12747671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Camrud</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Vlietstra</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-74</page-range>
            <pub-id pub-id-type="pmid">1732351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Dussaillant</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Satler</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.</article-title>
            <source>Circulation</source>
            <year>1996</year>
            <month>Sep</month>
            <day>15</day>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>1247</fpage>
            <page-range>1247-54</page-range>
            <pub-id pub-id-type="pmid">8822976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Glomset</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harker</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Response to injury and atherogenesis.</article-title>
            <source>Am J Pathol</source>
            <year>1977</year>
            <month>Mar</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>675</fpage>
            <page-range>675-84</page-range>
            <pub-id pub-id-type="pmid">842616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tung</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kaul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.</article-title>
            <source>Ann Intern Med</source>
            <year>2006</year>
            <month>Jun</month>
            <day>20</day>
            <volume>144</volume>
            <issue>12</issue>
            <fpage>913</fpage>
            <page-range>913-9</page-range>
            <pub-id pub-id-type="pmid">16785479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000fc;scher</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Steffel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eberli</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Joner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tanner</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>Feb</month>
            <day>27</day>
            <volume>115</volume>
            <issue>8</issue>
            <fpage>1051</fpage>
            <page-range>1051-8</page-range>
            <pub-id pub-id-type="pmid">17325255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbott</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Revealing the silver and red lining in drug-eluting stents with angioscopy.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-9</page-range>
            <pub-id pub-id-type="pmid">20031649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finn</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Joner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kolodgie</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Mont</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Vascular responses to drug eluting stents: importance of delayed healing.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>1500</fpage>
            <page-range>1500-10</page-range>
            <pub-id pub-id-type="pmid">17510464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries.</article-title>
            <source>Am J Cardiol</source>
            <year>2006</year>
            <month>Feb</month>
            <day>15</day>
            <volume>97</volume>
            <issue>4</issue>
            <fpage>506</fpage>
            <page-range>506-11</page-range>
            <pub-id pub-id-type="pmid">16461047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iakovou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bonizzoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ge</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sangiorgi</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Stankovic</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Airoldi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chieffo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montorfano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michev</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Corvaja</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Briguori</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gerckens</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Grube</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>May</month>
            <day>04</day>
            <volume>293</volume>
            <issue>17</issue>
            <fpage>2126</fpage>
            <page-range>2126-30</page-range>
            <pub-id pub-id-type="pmid">15870416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montalescot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hulot</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Stent thrombosis: who's guilty?</article-title>
            <source>Eur Heart J</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>22</issue>
            <fpage>2685</fpage>
            <page-range>2685-8</page-range>
            <pub-id pub-id-type="pmid">19854727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sourgounis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lipiecki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Hamon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Coronary stents and chronic anticoagulation.</article-title>
            <source>Circulation</source>
            <year>2009</year>
            <month>Mar</month>
            <day>31</day>
            <volume>119</volume>
            <issue>12</issue>
            <fpage>1682</fpage>
            <page-range>1682-8</page-range>
            <pub-id pub-id-type="pmid">19332481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otsuka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shuto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mitsudo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Comparison of pharmacokinetics of the limus-eluting stents in Japanese patients.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2011</year>
            <month>Dec</month>
            <day>01</day>
            <volume>78</volume>
            <issue>7</issue>
            <fpage>1078</fpage>
            <page-range>1078-85</page-range>
            <pub-id pub-id-type="pmid">21538783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chhatriwalla</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Cam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unzek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Lincoff</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Whitlow</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stent fracture and acute coronary syndrome.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2009</year>
            <season>Jul-Sep</season>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-71</page-range>
            <pub-id pub-id-type="pmid">19595398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aoki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hoye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Onuma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Higashikuni</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Otsuki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yagishita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yachi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2007</year>
            <month>Feb</month>
            <day>15</day>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>380</fpage>
            <page-range>380-6</page-range>
            <pub-id pub-id-type="pmid">17195199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Chae</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Yeon</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.</article-title>
            <source>J Korean Med Sci</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-8</page-range>
            <pub-id pub-id-type="pmid">21218030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Everett</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Desany</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5&#x000a0;Year Period in FDA MAUDE Database.</article-title>
            <source>Ann Biomed Eng</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>391</fpage>
            <page-range>391-403</page-range>
            <pub-id pub-id-type="pmid">26467552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conway</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Coronary Stent Fracture: Clinical Evidence Vs. the Testing Paradigm.</article-title>
            <source>Cardiovasc Eng Technol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>752</fpage>
            <page-range>752-760</page-range>
            <pub-id pub-id-type="pmid">30341730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wenaweser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Togni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Billinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seiler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>May</month>
            <day>08</day>
            <volume>115</volume>
            <issue>18</issue>
            <fpage>2426</fpage>
            <page-range>2426-34</page-range>
            <pub-id pub-id-type="pmid">17485593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Cheong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Jan</month>
            <day>24</day>
            <volume>113</volume>
            <issue>3</issue>
            <fpage>414</fpage>
            <page-range>414-9</page-range>
            <pub-id pub-id-type="pmid">16432073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butany</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carmichael</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery stents: identification and evaluation.</article-title>
            <source>J Clin Pathol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>58</volume>
            <issue>8</issue>
            <fpage>795</fpage>
            <page-range>795-804</page-range>
            <pub-id pub-id-type="pmid">16049279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertrand</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Sipehia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mongrain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tardif</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bilodeau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>C&#x000f4;t&#x000e9;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bourassa</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Biocompatibility aspects of new stent technology.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>562</fpage>
            <page-range>562-71</page-range>
            <pub-id pub-id-type="pmid">9741494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abizaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tanajura</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Solberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Larracas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Feres</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>Jde R</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2007</year>
            <month>Dec</month>
            <day>01</day>
            <volume>70</volume>
            <issue>7</issue>
            <fpage>914</fpage>
            <page-range>914-9</page-range>
            <pub-id pub-id-type="pmid">18044791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamm</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Beythien</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sievert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Utech</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Terres</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Reifart</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Multicenter evaluation of the Strecker tantalum stent for acute coronary occlusion after angioplasty.</article-title>
            <source>Am Heart J</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>423</fpage>
            <page-range>423-9</page-range>
            <pub-id pub-id-type="pmid">7872165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scott</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Viel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Harker</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Rowland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Juman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cipolla</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the thrombogenicity of stainless steel and tantalum coronary stents.</article-title>
            <source>Am Heart J</source>
            <year>1995</year>
            <month>May</month>
            <volume>129</volume>
            <issue>5</issue>
            <fpage>866</fpage>
            <page-range>866-72</page-range>
            <pub-id pub-id-type="pmid">7732974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoeckel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pelton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duerig</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Self-expanding nitinol stents: material and design considerations.</article-title>
            <source>Eur Radiol</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-301</page-range>
            <pub-id pub-id-type="pmid">12955452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zurakowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pajak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pajak-Zielinska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Liszka</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Buszman</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Bis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Debinski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buszman</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.</article-title>
            <source>Med Sci Monit</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>BR40</fpage>
            <page-range>BR40-4</page-range>
            <pub-id pub-id-type="pmid">20037484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menown</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Noad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Meredith</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The platinum chromium element stent platform: from alloy, to design, to clinical practice.</article-title>
            <source>Adv Ther</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>129</fpage>
            <page-range>129-41</page-range>
            <pub-id pub-id-type="pmid">20437213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koh</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Khin</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Chua</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Chia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry.</article-title>
            <source>Acute Card Care</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>219</fpage>
            <page-range>219-22</page-range>
            <pub-id pub-id-type="pmid">22142201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abreu Filho</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Forte</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sumita</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Favarato</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meireles</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2011</year>
            <volume>66</volume>
            <issue>6</issue>
            <fpage>985</fpage>
            <page-range>985-9</page-range>
            <pub-id pub-id-type="pmid">21808863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Youssef</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Hang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Cobalt chromium coronary stents and drug-eluting stents in real practice.</article-title>
            <source>Int Heart J</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-7</page-range>
            <pub-id pub-id-type="pmid">20716838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jorge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical utility of platinum chromium bare-metal stents in coronary heart disease.</article-title>
            <source>Med Devices (Auckl)</source>
            <year>2015</year>
            <volume>8</volume>
            <fpage>359</fpage>
            <page-range>359-67</page-range>
            <pub-id pub-id-type="pmid">26345228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zahedmanesh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lally</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis.</article-title>
            <source>Med Biol Eng Comput</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>385</fpage>
            <page-range>385-93</page-range>
            <pub-id pub-id-type="pmid">19189146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mehilli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dirschinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dotzer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;hlen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Fleckenstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pfafferott</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seyfarth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Jun</month>
            <day>12</day>
            <volume>103</volume>
            <issue>23</issue>
            <fpage>2816</fpage>
            <page-range>2816-21</page-range>
            <pub-id pub-id-type="pmid">11401938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slodownik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Danenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Merkin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Swaid</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moshe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ingber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lotan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Durst</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel.</article-title>
            <source>Cardiovasc J Afr</source>
            <string-date>2018 Jan/Feb 23</string-date>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-45</page-range>
            <pub-id pub-id-type="pmid">29443350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Stent implantation in patients with metal allergy: a systemic review and meta-analysis.</article-title>
            <source>Coron Artery Dis</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>684</fpage>
            <page-range>684-9</page-range>
            <pub-id pub-id-type="pmid">24135817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romero-Brufau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Best</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Lennon</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Outcomes after coronary stent implantation in patients with metal allergy.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>220</fpage>
            <page-range>220-6</page-range>
            <pub-id pub-id-type="pmid">22456027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurbel</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Malinin</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Serebruany</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Gillis</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>584</fpage>
            <page-range>584-9</page-range>
            <pub-id pub-id-type="pmid">12368510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dziewierz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dudek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.</article-title>
            <source>Kardiol Pol</source>
            <year>2018</year>
            <volume>76</volume>
            <issue>7</issue>
            <fpage>1043</fpage>
            <page-range>1043-1054</page-range>
            <pub-id pub-id-type="pmid">30251247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000f6;nig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haager</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Kerckhoff</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>vom Dahl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klauss</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hanrath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mudra</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study.</article-title>
            <source>Eur Heart J</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>21</issue>
            <fpage>2007</fpage>
            <page-range>2007-14</page-range>
            <pub-id pub-id-type="pmid">11603908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welt</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Inflammation and restenosis in the stent era.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>2002</year>
            <month>Nov</month>
            <day>01</day>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1769</fpage>
            <page-range>1769-76</page-range>
            <pub-id pub-id-type="pmid">12426203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haase</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>St&#x000f6;rger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Reinemer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>562</fpage>
            <page-range>562-5</page-range>
            <pub-id pub-id-type="pmid">14519887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finn</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Joner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kolodgie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>May</month>
            <day>08</day>
            <volume>115</volume>
            <issue>18</issue>
            <fpage>2435</fpage>
            <page-range>2435-41</page-range>
            <pub-id pub-id-type="pmid">17438147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moravej</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Biodegradable metals for cardiovascular stent application: interests and new opportunities.</article-title>
            <source>Int J Mol Sci</source>
            <year>2011</year>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>4250</fpage>
            <page-range>4250-70</page-range>
            <pub-id pub-id-type="pmid">21845076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gundogan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farhatnia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Alavijeh</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Seifalian</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Bioabsorbable stent quo vadis: a case for nano-theranostics.</article-title>
            <source>Theranostics</source>
            <year>2014</year>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>514</fpage>
            <page-range>514-33</page-range>
            <pub-id pub-id-type="pmid">24672583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Spriggs</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Shaughnessy</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>DeMaio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Koglin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>ME</given-names>
              </name>
              <collab>TAXUS V Investigators</collab>
            </person-group>
            <article-title>Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>Sep</month>
            <day>14</day>
            <volume>294</volume>
            <issue>10</issue>
            <fpage>1215</fpage>
            <page-range>1215-23</page-range>
            <pub-id pub-id-type="pmid">16160130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatterjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of Paclitaxel and sirolimus eluting stents.</article-title>
            <source>Curr Drug Metab</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>554</fpage>
            <page-range>554-66</page-range>
            <pub-id pub-id-type="pmid">18680476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Sirolimus for the prevention of in-stent restenosis in a coronary artery.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Oct</month>
            <day>02</day>
            <volume>349</volume>
            <issue>14</issue>
            <fpage>1307</fpage>
            <page-range>1307-9</page-range>
            <pub-id pub-id-type="pmid">14523135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abizaid</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sirolimus-eluting coronary stents: a review.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2007</year>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-201</page-range>
            <pub-id pub-id-type="pmid">17580729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levin</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Local and systemic drug competition in drug-eluting stent tissue deposition properties.</article-title>
            <source>J Control Release</source>
            <year>2005</year>
            <month>Dec</month>
            <day>05</day>
            <volume>109</volume>
            <issue>1-3</issue>
            <fpage>236</fpage>
            <page-range>236-43</page-range>
            <pub-id pub-id-type="pmid">16289420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wessely</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2006</year>
            <month>Feb</month>
            <day>21</day>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>708</fpage>
            <page-range>708-14</page-range>
            <pub-id pub-id-type="pmid">16487832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papafaklis</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Bourantas</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Theodorakis</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Katsouras</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Naka</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Fotiadis</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Michalis</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>11</issue>
            <fpage>1181</fpage>
            <page-range>1181-9</page-range>
            <pub-id pub-id-type="pmid">21087755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Shehata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rigg</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.</article-title>
            <source>Transplant Proc</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>2200</fpage>
            <page-range>2200-3</page-range>
            <pub-id pub-id-type="pmid">9723440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baetta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Granata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Canavesi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arnaboldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bellosta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pfister</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Corsini</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>328</volume>
            <issue>2</issue>
            <fpage>419</fpage>
            <page-range>419-25</page-range>
            <pub-id pub-id-type="pmid">19023042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Smits</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Ben-Yehuda</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Banai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kornowski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bagur</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Iniguez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danenberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jauhar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chandna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perlman</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Balcells</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Markham</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ozan</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Genereux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Oct</month>
            <day>03</day>
            <volume>136</volume>
            <issue>14</issue>
            <fpage>1304</fpage>
            <page-range>1304-1314</page-range>
            <pub-id pub-id-type="pmid">28794001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camici</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Steffel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amanovic</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Breitenstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baldinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>L&#x000fc;scher</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Tanner</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents.</article-title>
            <source>Eur Heart J</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>236</fpage>
            <page-range>236-42</page-range>
            <pub-id pub-id-type="pmid">19567381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Venkatraman</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Boey</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Lahti</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Umashankar</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arumugam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khanolkar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vaishnav</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>In vitro and in vivo performance of a dual drug-eluting stent (DDES).</article-title>
            <source>Biomaterials</source>
            <year>2010</year>
            <month>May</month>
            <volume>31</volume>
            <issue>15</issue>
            <fpage>4382</fpage>
            <page-range>4382-91</page-range>
            <pub-id pub-id-type="pmid">20189244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goo</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Joung</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Comparison of phytoncide with sirolimus as a novel drug candidate for drug-eluting stent.</article-title>
            <source>Biomaterials</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>44</volume>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">25617121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macdonald</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Panush</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Pepine</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.</article-title>
            <source>Am J Cardiol</source>
            <year>1987</year>
            <month>Jul</month>
            <day>31</day>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>56B</fpage>
            <page-range>56B-60B</page-range>
            <pub-id pub-id-type="pmid">2956845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer Zu Schwabedissen</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Begunk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hussner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Juhnke</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Gliesche</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ttcher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schmitz</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Kroemer</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices.</article-title>
            <source>Mol Pharm</source>
            <year>2014</year>
            <month>Mar</month>
            <day>03</day>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>665</fpage>
            <page-range>665-72</page-range>
            <pub-id pub-id-type="pmid">24495124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <day>15</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>8207</fpage>
            <pub-id pub-id-type="pmid">28811550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miyata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shirasawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Akasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tei</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model.</article-title>
            <source>Atherosclerosis</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>208</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-103</page-range>
            <pub-id pub-id-type="pmid">19682688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siller-Matula</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tentzeris</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schacherl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jarai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geppert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points.</article-title>
            <source>Clin Res Cardiol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>99</volume>
            <issue>10</issue>
            <fpage>645</fpage>
            <page-range>645-50</page-range>
            <pub-id pub-id-type="pmid">20405134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Melchert</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.</article-title>
            <source>Pharm Res</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>10</issue>
            <fpage>3213</fpage>
            <page-range>3213-27</page-range>
            <pub-id pub-id-type="pmid">25911596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Ormiston</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sianos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sousa</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Grube</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>den Heijer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Feyter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buszman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Polonski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thuesen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zeiher</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bett</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Suttorp</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Glogar</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Pitney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Whitbourn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Veldhof</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miquel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
              <collab>ACTION investigators</collab>
            </person-group>
            <article-title>Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Oct</month>
            <day>06</day>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>1363</fpage>
            <page-range>1363-7</page-range>
            <pub-id pub-id-type="pmid">15464314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of controlled drug release from drug-eluting stents.</article-title>
            <source>Adv Drug Deliv Rev</source>
            <year>2006</year>
            <month>Jun</month>
            <day>03</day>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>387</fpage>
            <page-range>387-401</page-range>
            <pub-id pub-id-type="pmid">16546289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizas</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mehilli</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Stent Polymers: Do They Make a Difference?</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27193905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gehman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of restenosis after placement of gold-coated stents.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Jul</month>
            <day>31</day>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>E23</fpage>
            <pub-id pub-id-type="pmid">11479268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dirschinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mehilli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>von Welser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pache</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;hlen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schilling</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.</article-title>
            <source>Circulation</source>
            <year>2000</year>
            <month>May</month>
            <day>30</day>
            <volume>101</volume>
            <issue>21</issue>
            <fpage>2478</fpage>
            <page-range>2478-83</page-range>
            <pub-id pub-id-type="pmid">10831521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinchuk</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Schoephoerster</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Parel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Medical applications of poly(styrene-block-isobutylene-block-styrene) ("SIBS").</article-title>
            <source>Biomaterials</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>448</fpage>
            <page-range>448-60</page-range>
            <pub-id pub-id-type="pmid">17980425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Busch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Strohbach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rethfeldt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Felix</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.</article-title>
            <source>Acta Biomater</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>688</fpage>
            <page-range>688-700</page-range>
            <pub-id pub-id-type="pmid">24148751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tyler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gullotti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mangraviti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Utsuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brem</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Polylactic acid (PLA) controlled delivery carriers for biomedical applications.</article-title>
            <source>Adv Drug Deliv Rev</source>
            <year>2016</year>
            <month>Dec</month>
            <day>15</day>
            <volume>107</volume>
            <fpage>163</fpage>
            <page-range>163-175</page-range>
            <pub-id pub-id-type="pmid">27426411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.</article-title>
            <source>Biomaterials</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>23</issue>
            <fpage>2475</fpage>
            <page-range>2475-90</page-range>
            <pub-id pub-id-type="pmid">11055295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sung</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Meredith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galis</surname>
                <given-names>ZS</given-names>
              </name>
            </person-group>
            <article-title>The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis.</article-title>
            <source>Biomaterials</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>26</issue>
            <fpage>5735</fpage>
            <page-range>5735-42</page-range>
            <pub-id pub-id-type="pmid">15147819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.</article-title>
            <source>Biomaterials</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>19</issue>
            <fpage>5151</fpage>
            <page-range>5151-8</page-range>
            <pub-id pub-id-type="pmid">20382420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pilgrim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stent technology: progress beyond the polymer.</article-title>
            <source>Eur Heart J</source>
            <year>2014</year>
            <month>Aug</month>
            <day>07</day>
            <volume>35</volume>
            <issue>30</issue>
            <fpage>1991</fpage>
            <page-range>1991-5</page-range>
            <pub-id pub-id-type="pmid">24908391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jing</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kirtane</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <collab>I-LOVE-IT 2 Investigators</collab>
            </person-group>
            <article-title>A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>1352</fpage>
            <page-range>1352-60</page-range>
            <pub-id pub-id-type="pmid">25440887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hausleiter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mehilli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;hlen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pache</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dotzer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sattelberger</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dirschinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.</article-title>
            <source>Am Heart J</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>146</volume>
            <issue>5</issue>
            <fpage>882</fpage>
            <page-range>882-6</page-range>
            <pub-id pub-id-type="pmid">14597939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakazawa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Finn</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kolodgie</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.</article-title>
            <source>Am J Cardiol</source>
            <year>2007</year>
            <month>Oct</month>
            <day>22</day>
            <volume>100</volume>
            <issue>8B</issue>
            <fpage>36M</fpage>
            <page-range>36M-44M</page-range>
            <pub-id pub-id-type="pmid">17950831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granada</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Huibregtse</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Dawkins</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>New stent design for use in small coronary arteries during percutaneous coronary intervention.</article-title>
            <source>Med Devices (Auckl)</source>
            <year>2010</year>
            <volume>3</volume>
            <fpage>57</fpage>
            <page-range>57-66</page-range>
            <pub-id pub-id-type="pmid">22915922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kanakadandi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fortuin</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Lassar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Composite outcomes in 2.25-mm drug eluting stents: a systematic review.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>237</fpage>
            <page-range>237-42</page-range>
            <pub-id pub-id-type="pmid">25976630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marroquin</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Selzer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mulukutla</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Vlachos</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Wilensky</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Tanguay</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Holper</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Kip</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>A comparison of bare-metal and drug-eluting stents for off-label indications.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Jan</month>
            <day>24</day>
            <volume>358</volume>
            <issue>4</issue>
            <fpage>342</fpage>
            <page-range>342-52</page-range>
            <pub-id pub-id-type="pmid">18216354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bundhun</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Bhurtu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soogund</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>MY</given-names>
              </name>
            </person-group>
            <article-title>Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>e0154064</fpage>
            <pub-id pub-id-type="pmid">27111304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Villablanca</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kolte</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hasan Khan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Velagapudi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kleiman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aronow</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Rosenfield</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Drachman</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Bangalore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Naidu</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis.</article-title>
            <source>Cardiol Rev</source>
            <year>2018</year>
            <season>Nov/Dec</season>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>277</fpage>
            <page-range>277-286</page-range>
            <pub-id pub-id-type="pmid">30157064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Witzenbichler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guagliumi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Peruga</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Dudek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kornowski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Pocock</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dangas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Fahy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parise</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <collab>HORIZONS-AMI Trial Investigators</collab>
            </person-group>
            <article-title>Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2011</year>
            <month>Jun</month>
            <day>25</day>
            <volume>377</volume>
            <issue>9784</issue>
            <fpage>2193</fpage>
            <page-range>2193-204</page-range>
            <pub-id pub-id-type="pmid">21665265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iakovou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ge</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Contemporary stent treatment of coronary bifurcations.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2005</year>
            <month>Oct</month>
            <day>18</day>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>1446</fpage>
            <page-range>1446-55</page-range>
            <pub-id pub-id-type="pmid">16226167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Bare-Metal Stent and Drug-Eluting Stent for the Treatment of Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease - Long-Term Result from a Single Center Experience.</article-title>
            <source>Acta Cardiol Sin</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>381</fpage>
            <page-range>381-9</page-range>
            <pub-id pub-id-type="pmid">27122897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Briguori</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Should We Still Have Bare-Metal Stents&#x000a0;Available in Our Catheterization&#x000a0;Laboratory?</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>607</fpage>
            <page-range>607-619</page-range>
            <pub-id pub-id-type="pmid">28750704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Boland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>D&#x000fc;ndar</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Haycox</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mujica Mota</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bagust</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Drug-eluting stents: a systematic review and economic evaluation.</article-title>
            <source>Health Technol Assess</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>46</issue>
            <fpage>iii</fpage>
            <page-range>iii, xi-221</page-range>
            <pub-id pub-id-type="pmid">17999841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rinfret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Tahami Monfared</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lelorier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mireault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schampaert</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.</article-title>
            <source>Am J Cardiovasc Drugs</source>
            <year>2006</year>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-68</page-range>
            <pub-id pub-id-type="pmid">16780389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goeree</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Blackhouse</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lazzam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tarride</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.</article-title>
            <source>Int J Technol Assess Health Care</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-207</page-range>
            <pub-id pub-id-type="pmid">19331710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Turco</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gurbel</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2011</year>
            <month>May</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-50</page-range>
            <pub-id pub-id-type="pmid">21596327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rehman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thyagarajan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Kleiman</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>New-Generation Coronary Stents: Current Data and Future Directions.</article-title>
            <source>Curr Atheroscler Rep</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">28220461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puranik</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Peppas</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in drug eluting stents.</article-title>
            <source>Int J Pharm</source>
            <year>2013</year>
            <month>Jan</month>
            <day>30</day>
            <volume>441</volume>
            <issue>1-2</issue>
            <fpage>665</fpage>
            <page-range>665-79</page-range>
            <pub-id pub-id-type="pmid">23117022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-210.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>de la Torre Hernandez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The Newest Generation of Drug-eluting Stents and Beyond.</article-title>
            <source>Eur Cardiol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-59</page-range>
            <pub-id pub-id-type="pmid">30310472</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
